Regulatory agencies like the FDA and EPA recognize the importance of both in vitro and in vivo methods in toxicology. In vitro assays are increasingly accepted as part of a tiered testing strategy, particularly for initial screenings. However, in vivo studies remain crucial for definitive risk assessments and are often required for the approval of new drugs, chemicals, and consumer products.
